Carla Barbaraci

A Structure- and Ligand-Based Virtual Screening of a Database of “Small” Marine Natural Products for the Identification of “Blue” Sigma-2 Receptor Ligands

R. Turnaturi, A. Rescifina, G. Floresta, 2018, Marine drugs.

Haloperidol Metabolite II Valproate Ester (S)-(−)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma

G. Pitari, G. Lupo, G. Giurdanella, 2021, Journal of medicinal chemistry.

Interaction of new sigma ligands with biomembrane models evaluated by differential scanning calorimetry and Langmuir-Blodgett studies.

F. Castelli, A. Marrazzo, E. Amata, 2021, Colloids and surfaces. B, Biointerfaces.

Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents

M. Gariboldi, R. Turnaturi, A. Rescifina, 2021, Journal of medicinal chemistry.

Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation.

R. Turnaturi, L. Pasquinucci, M. Dichiara, 2022, European journal of medicinal chemistry.

Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands

C. Parenti, L. Pasquinucci, S. Alcaro, 2023, ACS chemical neuroscience.

Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity.

A. Cataldi, M. Rapino, A. Rescifina, 2023, Bioorganic chemistry.

Nanostructured lipid carrier for the ophthalmic delivery of haloperidol metabolite II valproate ester (±)-MRJF22: A potential strategy in the treatment of uveal melanoma

G. Pitari, R. Pignatello, A. Marrazzo, 2023, Journal of Drug Delivery Science and Technology.